(120) Cluster differentiation-modified liposomes for lung targeted anti-inflammatory therapy
Introduction: Inhalable nanocarriers represent a promising approach for the treatment of respiratory and inflammatory diseases affecting the pulmonary system, with the potential to prevent disease progression and minimize tissue damage. Here, we propose a liposome modified with a cluster of differentiation protein for targeted anti-inflammatory therapy.
Learning Objectives:
Develop a liposome with modified surface using a cluster differentiation protein.
Understand what the implications and importance of inhalable nanoparticles for respiratory diseases.
Nathalia Oliveira – PhD, School of Pharmacy, Federal University of Goiás, Goiania, 74690-631, Brazil, UFG; Edilson Oliveira Junior – PhD, School of Pharmacy, Federal University of Goiás, Goiania, 74690-631, Brazil, UFG; Kleber Silva – PhD, School of Pharmacy, Federal University of Goiás, Goiania, 74690-631, Brazil, UFG; Marcilia Pavam – Master, School of Pharmacy, Federal University of Goiás, Goiania, 74690-631, Brazil, UFG; Sebastião Mendanha – Professor, Institute of Physics, Federal University of Goiás, Goiânia , Goiás, 74690-900 - Brazil, UFG; Eliana Lima – Professor, School of Pharmacy, Federal University of Goiás, Goiania, 74690-631, Brazil, UFG
